SEHK:1779Biotechs
LongBio Pharma (Suzhou) (SEHK:1779) Stock Valuation Looks Stretched After Recent Gain And High P/B Ratio
Event overview and immediate market reaction
LongBio Pharma (Suzhou) (SEHK:1779) moved higher in the latest session, with the stock closing at HK$141.9 after a 3.2% gain for the day, drawing fresh attention from biotech focused investors.
See our latest analysis for LongBio Pharma (Suzhou).
The 3.2% one day share price return fits into a year to date share price return of 7.66%. This suggests momentum has been gradually building as investors reassess LongBio Pharma (Suzhou)'s risk and growth...